191 related articles for article (PubMed ID: 26042772)
1. Trypanothione reductase: a target protein for a combined in vitro and in silico screening approach.
Beig M; Oellien F; Garoff L; Noack S; Krauth-Siegel RL; Selzer PM
PLoS Negl Trop Dis; 2015; 9(6):e0003773. PubMed ID: 26042772
[TBL] [Abstract][Full Text] [Related]
2. Identification of potential trypanothione reductase inhibitors among commercially available β-carboline derivatives using chemical space, lead-like and drug-like filters, pharmacophore models and molecular docking.
Rodríguez-Becerra J; Cáceres-Jensen L; Hernández-Ramos J; Barrientos L
Mol Divers; 2017 Aug; 21(3):697-711. PubMed ID: 28656524
[TBL] [Abstract][Full Text] [Related]
3. Crystal structure of Trypanosoma cruzi trypanothione reductase in complex with trypanothione, and the structure-based discovery of new natural product inhibitors.
Bond CS; Zhang Y; Berriman M; Cunningham ML; Fairlamb AH; Hunter WN
Structure; 1999 Jan; 7(1):81-9. PubMed ID: 10368274
[TBL] [Abstract][Full Text] [Related]
4. Structural analysis and molecular docking of trypanocidal aryloxy-quinones in trypanothione and glutathione reductases: a comparison with biochemical data.
Vera B; Vázquez K; Mascayano C; Tapia RA; Espinosa V; Soto-Delgado J; Salas CO; Paulino M
J Biomol Struct Dyn; 2017 Jun; 35(8):1785-1803. PubMed ID: 27232454
[TBL] [Abstract][Full Text] [Related]
5. Trypanocidal bisbenzylisoquinoline alkaloids are inhibitors of trypanothione reductase.
Fournet A; Inchausti A; Yaluff G; Rojas De Arias A; Guinaudeau H; Bruneton J; Breidenbach MA; Karplus PA; Faerman CH
J Enzyme Inhib; 1998 Feb; 13(1):1-9. PubMed ID: 9879510
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and evaluation of substrate analogue inhibitors of trypanothione reductase.
Duyzend MH; Clark CT; Simmons SL; Johnson WB; Larson AM; Leconte AM; Wills AW; Ginder-Vogel M; Wilhelm AK; Czechowicz JA; Alberg DG
J Enzyme Inhib Med Chem; 2012 Dec; 27(6):784-94. PubMed ID: 22085139
[TBL] [Abstract][Full Text] [Related]
7. Rational design of nitrofuran derivatives: Synthesis and valuation as inhibitors of Trypanosoma cruzi trypanothione reductase.
Arias DG; Herrera FE; Garay AS; Rodrigues D; Forastieri PS; Luna LE; Bürgi MD; Prieto C; Iglesias AA; Cravero RM; Guerrero SA
Eur J Med Chem; 2017 Jan; 125():1088-1097. PubMed ID: 27810595
[TBL] [Abstract][Full Text] [Related]
8. Toward the development of dual-targeted glyceraldehyde-3-phosphate dehydrogenase/trypanothione reductase inhibitors against Trypanosoma brucei and Trypanosoma cruzi.
Belluti F; Uliassi E; Veronesi G; Bergamini C; Kaiser M; Brun R; Viola A; Fato R; Michels PA; Krauth-Siegel RL; Cavalli A; Bolognesi ML
ChemMedChem; 2014 Feb; 9(2):371-82. PubMed ID: 24403089
[TBL] [Abstract][Full Text] [Related]
9. New spermine and spermidine derivatives as potent inhibitors of Trypanosoma cruzi trypanothione reductase.
Bonnet B; Soullez D; Davioud-Charvet E; Landry V; Horvath D; Sergheraert C
Bioorg Med Chem; 1997 Jul; 5(7):1249-56. PubMed ID: 9377084
[TBL] [Abstract][Full Text] [Related]
10. Polyamines with N-(3-phenylpropyl) substituents are effective competitive inhibitors of trypanothione reductase and trypanocidal agents.
Li Z; Fennie MW; Ganem B; Hancock MT; Kobaslija M; Rattendi D; Bacchi CJ; O'Sullivan MC
Bioorg Med Chem Lett; 2001 Jan; 11(2):251-4. PubMed ID: 11206471
[TBL] [Abstract][Full Text] [Related]
11. Polyamine derivatives as inhibitors of trypanothione reductase and assessment of their trypanocidal activities.
O'Sullivan MC; Zhou Q; Li Z; Durham TB; Rattendi D; Lane S; Bacchi CJ
Bioorg Med Chem; 1997 Dec; 5(12):2145-55. PubMed ID: 9459012
[TBL] [Abstract][Full Text] [Related]
12. Trypanothione Reductase: A Target for the Development of Anti- Trypanosoma cruzi Drugs.
Vázquez K; Paulino M; Salas CO; Zarate-Ramos JJ; Vera B; Rivera G
Mini Rev Med Chem; 2017; 17(11):939-946. PubMed ID: 28302040
[TBL] [Abstract][Full Text] [Related]
13. Arylfurans as potential trypanosoma cruzi trypanothione reductase inhibitors.
de Oliveira RB; Vaz AB; Alves RO; Liarte DB; Donnici CL; Romanha AJ; Zani CL
Mem Inst Oswaldo Cruz; 2006 Mar; 101(2):169-73. PubMed ID: 16830710
[TBL] [Abstract][Full Text] [Related]
14. Trypanothione Reductase and Superoxide Dismutase as Current Drug Targets for Trypanosoma cruzi: An Overview of Compounds with Activity against Chagas Disease.
Beltran-Hortelano I; Perez-Silanes S; Galiano S
Curr Med Chem; 2017 May; 24(11):1066-1138. PubMed ID: 28025938
[TBL] [Abstract][Full Text] [Related]
15. Phenothiazine inhibitors of trypanothione reductase as potential antitrypanosomal and antileishmanial drugs.
Chan C; Yin H; Garforth J; McKie JH; Jaouhari R; Speers P; Douglas KT; Rock PJ; Yardley V; Croft SL; Fairlamb AH
J Med Chem; 1998 Jan; 41(2):148-56. PubMed ID: 9457238
[TBL] [Abstract][Full Text] [Related]
16. Inhibitors of trypanothione reductase as potential antitrypanosomal drugs.
Chan C; Yin H; Garforth J; McKie JH; Jaouhari RA; Douglas KT; Fairlamb AH; Croft SL
Biochem Soc Trans; 1995 Nov; 23(4):511S. PubMed ID: 8654696
[No Abstract] [Full Text] [Related]
17. The synthesis and inhibitory activity of dethiotrypanothione and analogues against trypanothione reductase.
Czechowicz JA; Wilhelm AK; Spalding MD; Larson AM; Engel LK; Alberg DG
J Org Chem; 2007 May; 72(10):3689-93. PubMed ID: 17439174
[TBL] [Abstract][Full Text] [Related]
18. Recent Advancement in the Search of Innovative Antiprotozoal Agents Targeting Trypanothione Metabolism.
Saccoliti F; Di Santo R; Costi R
ChemMedChem; 2020 Dec; 15(24):2420-2435. PubMed ID: 32805075
[TBL] [Abstract][Full Text] [Related]
19. Crystal structure of the Trypanosoma cruzi trypanothione reductase.mepacrine complex.
Jacoby EM; Schlichting I; Lantwin CB; Kabsch W; Krauth-Siegel RL
Proteins; 1996 Jan; 24(1):73-80. PubMed ID: 8628734
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and biological evaluation of new potent 5-nitrofuryl derivatives as anti-Trypanosoma cruzi agents. Studies of trypanothione binding site of trypanothione reductase as target for rational design.
Aguirre G; Cabrera E; Cerecetto H; Di Maio R; González M; Seoane G; Duffaut A; Denicola A; Gil MJ; Martínez-Merino V
Eur J Med Chem; 2004 May; 39(5):421-31. PubMed ID: 15110968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
